Quantcast Free Webinar: Immunology and Drug Development | NFCA
Skip Navigation Links

Free Webinar: Immunology and Drug Development

NFCA webinars

Do you know how celiac disease works?

Celiac disease research continues to prove the need for a non-dietary therapy, and scientists are moving closer to developing a pharmaceutical treatment. Now, it is more important than ever for patients to learn about the field of immunology - a critical piece to the celiac disease puzzle that is often left out of patient education - as well as understand the basics about the drug development and approval process.

The National Foundation for Celiac Awareness (NFCA) welcomed two immunology and pharmacology experts for a 1-hour discussion on this topic. The webinar recording and slides are now available for you to download on demand.

Webinar Details

Topic: Celiac Disease: Immunology 101 and the Drug Development Process

Speakers:

  • Ken Kilgore, MS, PhD, Director of ImmunoPharmacology in the Immunology Therapeutic Area at Janssen Pharmaceutical Companies of Johnson and Johnson, and Executive of NFCA Scientific/Medical Advisory Council
  • Francisco Leon, MD, PhD, Vice President of Immunology Translational Medicine at Janssen Pharmaceutical Companies of Johnson and Johnson

Download & Watch the Webinar

PDF symbol Download the Webinar Slides

Additional Resources

Potential Pharmaceutical Treatments for Celiac Disease
Interview with Joseph Murray, MD, celiac disease expert from the Mayo Clinic and member of NFCA's Scientific/Medical Advisory Council

 

Share your feedback!

This webpage...

 



 
  • Have you or your family members been diagnosed?
    Complete our celiac disease symptoms checklist today to find out if you are at risk of having celiac disease or non-celiac gluten sensitivity ('gluten sensitivity').  We can help improve your quality of life!
  • Stay Informed!
    Join our monthly newsletter to receive news, updates, and tips for healthy gluten-free living and information about celiac disease. Sign-up for the monthly e-mail newsletter